Dear SOT Members,
Below are a number of SOT-sponsored meetings and events that may be of interest to you. For more information, contact the organizers directly.
Drug Safety: Bridging the Divide Between Preclinical and Clinical Drug Safety—June 1–6, 2014
A Gordon Research Conference on Drug Safety: Bridging the Divide Between Preclinical and Clinical Drug Safety, will be held June 1‒6 at Stonehill College, Easton, Massachusetts. The goals of this new conference are to stimulate discussion of contemporary approaches to assessing drug safety and to bridge the divide that exists between individuals working in pre-clinical and clinical drug safety research. An additional objective is to catalyze discussions among drug safety experts in academia and industry, so as to create opportunities for collaboration and to strengthen the valuable relationship between basic and applied research in the field of drug safety. The target audience is an equal mix of academic and industry scientists striving to improve drug safety. Funding is available for graduate students and postdoctoral fellows who are presenting outstanding posters. Full program details are available on the conference website as well as the application to attend this conference.
Society of Toxicologic Pathology 33rd Annual Symposium—June 22–26, 2014
“Translational Pathology: Relevance of Toxicologic Pathology to Human Health” is the theme of the Society of Toxicologic Pathology (STP) 33rd Annual Symposium, which will be held June 22–26, 2014, at the Marriott Wardman Park Hotel in Washington, DC. Topics will include the predictive value of nonclinical models and how animal models and human endpoints inform each other, progress in the development of new nonclinical animal models and other types of models, emerging technologies that have the potential to improve translational capabilities, the role and utility of epigenetic endpoints in toxicologic pathology and their relevance to human health, how pathology outcomes inform human health assessments and regulatory decisions, and the challenges of developing translational models that provide useful information on human populations with comorbidities. By the end of this symposium, the audience will have a better understanding of current trends and data needs in translational pathology and how the field can leverage expertise and tools to meet these needs. An interactive pre-meeting National Toxicology Program (NTP) Satellite Symposium will be held on Saturday, June 21, and four Continuing Education (CE) Courses will be offered on Sunday, June 22. The scientific sessions on Tuesday, June 24, have been designed in response to requests from the Federal regulatory community. US Government employees may register by June 1 to attend Tuesday sessions at no charge. Visit the 2014 STP Annual Meeting website to view the program and additional meeting details on exhibits, sessions, CE courses, and special events
Teratology Society 54th Annual Meeting—June 28–July 2, 2014
The theme of the 54th Annual Meeting of the Teratology Society is “Pushing the Boundaries of Birth Defects Research.” The meeting will highlight the latest scientific information and technology in birth defects and developmental disabilities research. Symposium topics include early prenatal diagnosis of birth defects, testicular dysgenesis syndrome, epigenetics, and thrombosis during pregnancy. The meeting also will feature special programs for the next generation of birth defects researchers including a workshop on building a career in developmental toxicology and a NEW Student Innovative Design Competition for improving prenatal development and child health. This competition asks students to imagine novel solutions to technical problems in the broad field of teratology—encompassing anything from a new measurement technique for exposure to environmental contaminants during pregnancy to a wireless method for assessing fetal health. The interdisciplinary nature of the Society provides unique opportunities to look broadly at complex issues. The Annual Meeting will be held June 28–July 2, 2014, in Bellevue, Washington, located on the eastside of Seattle. For more information, visit the Teratology Society Annual Meeting website.
SOT CCT Toxicity of Biodiesel and Other Biofuels: Implications for Global Use—September 4–5, Edinburgh
"Toxicity of Biodiesel and Other Biofuels: Implications for Global Use" SOT Contemporary Concepts in Toxicology (CCT) conference will be held September 4–5, 2014, at the University of Edinburgh Campus, Edinburgh, Scotland. The conference overview notes that: "The need for nonpetroleum based alternative energy sources is based on many factors, including increased energy demands, available sources, economic influences, and toxicity of the energy source. Liquid biofuels, such as biodiesel, have been proposed as a possible energy source with widespread usage, especially for mobile applications such as transportation. In order to better and more fully assess the role liquid biofuels can play in our current and future energy needs, a complete picture of the advantages and disadvantages of the use of liquid biofuels needs to emerge, which will in turn allow for informed decisions to be made by policymakers." The purpose of this conference is to bring together interested parties and experts in primarily the biodiesel arena to present state-of-the-art knowledge on the production, chemistry, combustion engineering, and toxicology of this fuel. Conference goals include: 1) providing knowledge to toxicologists regarding current biofuels usage and estimates for the future (for research planning); 2) linkage of toxicity to biodiesel chemical markers in the fuel or emissions; and 3) compare biodiesel toxicity endpoints with petroleum fuel toxicity for various health outcomes. The understanding that evolves from this conference will help lead to a better focus on the more appropriate liquid fuel sources that will be developed in the future. For additional information and to register for this CCT conference, please visit the SOT website.
Environmental Mutagenesis and Genomics Society 45th Annual Meeting—September 13–17, 2014
The 45th Annual Meeting of the Environmental Mutagenesis and Genomics Society (EMGS) will be held September 13–17, 2014, at the Hilton Orlando Lake Buena Vista, in Orlando, Florida. This year’s theme is “Integrating Environmental, Genomic, and Health Research.” The meeting will provide a forum for the latest research on DNA damage and repair, mechanisms of mutagenesis, epigenetic regulation, and their contributions to environmentally-induced human disease. In addition, current regulatory issues and risk assessment strategies will be discussed. EMGS is unique in that it provides a platform for the cross-disciplinary integration of basic and applied sciences that provide an understanding of the impact of genetic toxicity on human populations.The goals of this meeting are to (1) build on our past contributions to the field of environmental and molecular mutagenesis and DNA repair and more fully understand the role of epigenetics in these basic mechanisms; (2) integrate applied genetic toxicology with basic research in DNA damage and repair, toxicogenomics, and epigenetics; (3) determine how emerging technologies can lead to a better understanding of environmentally-induced genetic disease; (4) have these data serve as a foundation for human risk assessment for disease and disease prevention; and (5) aid in the support of knowledge-based regulation to protect public health and the environment. This is a meeting not to be missed. For additional information, visit the EMGS 2014 Annual Meeting website.
Safety Pharmacology Society 14th Annual Meeting, October 19–22, 2014, Washington, DC
The Safety Pharmacology Society (SPS) 14th Annual Meeting will be held October 19–22, 2014, in Washington, DC and will provide a dynamic forum for sharing the latest in safety pharmacology. The scientific program will offer in-depth discussions of relevant topics to keep you “in the know.” This meeting will feature a diverse range of scientific sessions organized into two tracks, covering issues such as, Cardiovascular, Central Nervous System, Non Cardiac Ion Channels, Respiratory, Regulatory, New Assays, Peripheral Neuropathy, and an all day Plenary on Wednesday covering the Updates and Perspectives on Comprehensive In Vitro Proarrhythmia Assay (CIPA). The meeting also will offer a full day of Continuing Education courses on October 19, both on an introductory level as well as advanced courses for the expert, and the Diplomate in Safety Pharmacology (DSP) Certification exam will be held the day before the meeting on October 18. For preliminary meeting information, please visit the SPS Annual Meeting website.
American College of Toxicology’s 35th Annual Meeting, November 9–12, 2014, Orlando, Florida
The American College of Toxicology (ACT) Annual Meeting provides an ideal venue for keeping abreast of emerging trends in the discipline of toxicology, for staying connected with friends and colleagues, and for making new connections. This year’s annual meeting will include a world-class scientific program, a unique welcoming reception venue, our popular traditional poster/reception session, more social/functional events in the exhibit hall to enhance broad interactions among attendees, students, and exhibitors, and much more.The ACT Annual Meeting is the perfect blend of educational resource and interpersonal engagement for toxicologists working to stay at the top of their game. Please join us at a beautiful Orlando resort for what is sure to be another memorable ACT Annual Meeting. For more information, visit the ACT Annual Meeting website.